The cardiovascular effects of central hydrogen sulfide are related to KATP channels activation

Physiological Research

Volumn 60, Issue 5, 2011, Pages 729-738

  Liu, W Q ^a,b   Chai, C ^c   Li, X Y ^a   Yuan, W J ^d,e   Wang, W Z ^d   Lu, Y ^a  

^a San Ai Tang Hospital   (China)

^b Daxing District People's Hospital   (China)

^c LANZHOU UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Blood pressure; Central; Heart rate; Hydrogen sulfide; Rat

Indexed keywords

EID: 84863012733     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.932092     Document Type: Article

References (39)

1. ABE K, KIMURA H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16: 1066-1071, 1996.
2. AGUILAR-BRYAN L, BRYAN J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20: 101-135, 1999.
3. 2 underlies glutamatedependent inhibition of striatal dopamine release. Proc Natl Acad Sci U S A 100: 11729-11734, 2003.
4. ATP channels. Annu Rev Physiol 60: 667-687, 1998.
5. BEAUCHAMP RO Jr, BUS JS, POPP JA, BOREIKO CJ, ANDJELKOVICH DA. A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol 13: 25-97, 1984.
6. BELTOWSKI J. Hydrogen sulfide as a biologically active mediator in the cardiovascular system. (in Polish) Postepy Hig Med Dosw (Online) 58: 285-291, 2004.
7. BOEHNING D, SNYDER SH. Novel neural modulators. Annu Rev Neurosci 26: 105-131, 2003.
8. CABRERA C, BOHR D. The role of nitric oxide in the central control of blood pressure. Biochem Biophys Res Commun 206: 77-81, 1995.
9. CHEN CQ, XIN H, ZHU YZ. Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential. Acta Pharmacol Sin 28: 1709-1716, 2007.
10. DALLAPORTA M, PERRIN J, ORSINI JC. Involvement of adenosine triphosphate-sensitive K+ channels in glucosesensing in the rat solitary tract nucleus. Neurosci Lett 278: 77-80, 2000.
11. + channel-dependent decrease in blood pressure in freely moving rats. Neuroscience 152: 169-177, 2008.
12. ATP channels. J Pharmacol Exp Ther 316: 325-335, 2006.
13. DOMBKOWSKI RA, RUSSELL MJ, OLSON KR. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol 286: R678-R685, 2004.
14. ETO K, OGASAWARA M, UMEMURA K, NAGAI Y, KIMURA H. Hydrogen sulfide is produced in response to neuronal excitation. J Neurosci 22: 3386-3391, 2002.
15. FERREIRA M Jr., BROWNING KN, SAHIBZADA N, VERBALIS JG, GILLIS RA, TRAVAGLI RA. Glucose effects on gastric motility and tone evoked from the rat dorsal vagal complex. J Physiol 536: 141-152, 2001.
16. FINKELSTEIN JD. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med 45: 1694-1699, 2007.
17. FURNE J, SAEED A, LEVITT MD. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values Am J Physiol Regul Integr Comp Physiol 295: R1479-R1485, 2008.
18. GALLEGO D, CLAVE P, DONOVAN J, RAHMATI R, GRUNDY D, JIMENEZ M, BEYAK MJ. The gaseous mediator, hydrogen sulphide, inhibits in vitro motor patterns in the human, rat and mouse colon and jejunum. Neurogastroenterol Motil 20: 1306-1316, 2008.
19. GENG B, CUI Y, ZHAO J, YU F, ZHU Y, XU G, ZHANG Z, TANG C, DU J. Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats. Am J Physiol Regul Integr Comp Physiol 293: R1608-R1618, 2007.
20. HAN Y, QIN J, CHANG X, YANG Z, TANG X, DU J. Hydrogen sulfide may improve the hippocampal damage induced by recurrent febrile seizures in rats. Biochem Biophys Res Commun 327: 431-436, 2005.
21. HOSOKI R, MATSUKI N, KIMURA H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237: 527-531, 1997.
22. HUANG Y. Hydrogen Sulfide Affects Presympathetic Neurons in RVLM in Rats. Second Military Medical University, Shanghai, 2008.
23. ATP channels by its actions on nucleotide binding folds 1 and 2 of sulfonylurea receptor 2A. J Biol Chem 279: 47125-47131, 2004.
24. KIMURA H. Hydrogen sulfide as a neuromodulator. Mol Neurobiol 26: 13-19, 2002.
25. LAGGNER H, HERMANN M, ESTERBAUER H, MUELLNER MK, EXNER M, GMEINER BM, KAPIOTIS S. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens 25: 2100-2104, 2007.
26. LIN MT, PAN SP, LIN JH, YANG YL. Central control of blood pressure by nitrergic mechanisms in organum vasculosum laminae terminalis of rat brain. Br J Pharmacol 127: 1511-1517, 1999.
27. LISS B, ROEPER J. Molecular physiology of neuronal K-ATP channels (review). Mol Membr Biol 18: 117-127, 2001.
28. 2S) - the third gas of interest for pharmacologists. Pharmacol Rep 59: 4-24, 2007.
29. LU Y, WANG LG, LIAO Z, TANG CS, WANG WZ, YUAN WJ. Cardiovascular effects of centrally applied endothelin-1 1-31 and its relationship to endothelin-1 1-21 in rats. Auton Neurosci 133: 146-152, 2007.
30. LU Y, WANG WZ, LIAO Z, YAN XH, TANG CS, YUAN WJ. Blood pressure responses of endothelin-1 1-31 within the rostral ventrolateral medulla through conversion to endothelin-1 1-21. J Cardiovasc Pharmacol 46: 823-829, 2005.
31. + channels as metabolic sensors: studies of Kir6.x null mice Diabetes 53 (Suppl 3): S176-S180, 2004.
32. + channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling. Am J Physiol Endocrinol Metab 285: E1289-E1296, 2003.
33. + channels in arterial pressure regulation during acute cerebral ischaemia in SHR and WKY rats. Clin Exp Pharmacol Physiol Suppl 22: S70-S72, 1995a.
34. NISHIMURA M, TAKAHASHI H, NANBU A, SAKAMOTO M, NAKANISHI T, YOSHIMURA M. Cerebral ATPsensitive potassium channels during acute reduction of carotid blood flow. Hypertension 25: 1069-1074, 1995b.
35. - donor NaHS releases nitric oxide from nitrosothiols, metal nitrosyl complex, brain homogenate and murine L1210 leukaemia cells. Pflugers Arch 457: 271-279, 2008.
36. REIFFENSTEIN RJ, HULBERT WC, ROTH SH. Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol 32: 109-134, 1992.
37. SOUNDARAPANDIAN MM, WU D, ZHONG X, PETRALIA RS, PENG L, TU W, LU Y. Expression of functional Kir6.1 channels regulates glutamate release at CA3 synapses in generation of epileptic form of seizures. J Neurochem 103: 1982-1988, 2007.
38. TANG G, WU L, LIANG W, WANG R. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol 68: 1757-1764, 2005.
39. TEAGUE B, ASIEDU S, MOORE PK. The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol 137: 139-145, 2002.